Belite Bio initiated at Buy by Canaccord Genuity
Canaccord Genuity initiated coverage on Belite Bio with a Buy rating and set a $303.00 per-share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.